Navigation Links
Olive Fertility Centre Physician Recognized for Excellence
Date:4/3/2013

Vancouver, Canada (PRWEB) April 03, 2013

Olive Fertility Centre is proud to announce that co-founder and co-director Dr. Jason Hitkari has been awarded the Outstanding Educator Award on behalf of the UBC medical class of 2014 for his contribution as Reproduction Week chair and lecturer. This is the second time Dr. Hitkari has received this award acknowledging the recipient for “extraordinary commitment to teaching and making a significant contribution to learning.”

“This award is a tremendous honour,” says Dr. Hitkari. “Reproductive Endocrinology is an exciting and rapidly changing field. And just as our technology is advancing, so is our model of patient care. As a practicing fertility doctor and educator, I am delighted to have the opportunity to share my experience and insight into fertility treatment with this talented group of future physicians.”

Dr. Hitkari is currently extremely involved in medical student education in reproduction and infertility at UBC. He also coordinates the Reproduction Seminars for the Obstetrics and Gynecology resident physicians and lectures extensively throughout BC to family practitioners, family practice residents, allied health professionals, and gynecologists.

After completing his training in Obstetrics and Gynecology at the University of British Columbia, Dr. Hitkari went on to do a formal fellowship in Reproductive Endocrinology and Infertility at Mt. Sinai Hospital in Toronto. He then returned to Vancouver, where he joined Genesis Fertility Centre as a co-director. In 2013, Dr. Hitkari left Genesis to open a new clinic, Olive Fertility Centre, with Drs. Taylor, Yuzpe, and Fluker.

“Olive Fertility Centre has been up and running since January 2013, but we are looking forward to moving into our brand new clinic at City Square in Vancouver in June 2013. We have some of the most experienced fertility specialists in Canada as part of our physician team, and we ar
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Olive Dental Group Announces a New Treatment for Sleep Apnea
2. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
3. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
4. d’Oliveira & Associates Seeks Clients That Have Been Affected by the Prescription Drug Topamax
5. d'Oliveira & Associates Offers “No Win - No Fee Promise” on Topamax Cases
6. Explaining how extra virgin olive oil protects against Alzheimers disease
7. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
8. d'Oliveira & Associates Helps Massachusetts Man Receive $100,000 in Auto Accident Settlement
9. D’Oliveira & Associates Helps Woonsocket, RI Man Receive Over $38,000 in Back Due Benefits
10. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
11. d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... April 24, 2014 ,Take me out to the ... and kale chips. The more likely culprits include French ... , Unfortunately for children who play youth baseball, eating ... to weight problems, according to researchers at Wake Forest ... online edition of Childhood Obesity , found that ...
(Date:4/24/2014)... Center for BrainHealth will bring together national experts ... challenges at its inaugural Brain Health Summit, titled ... speakers will include Dr. Sandra Bond Chapman, founder ... U.S. Senator Chuck Grassley (R-IA), U.S. Representative Chaka ... for Policy and Early Learning, U.S. Department of ...
(Date:4/24/2014)... Fibroblasts, cells long thought to be boring and irrelevant, ... with heart disease. , Researcher Dr Milena Furtado, and ... at Monash University, found the heart cell fibroblast is ... for a healthy beating heart. , In research published ... found that cardiac fibroblasts are unique cells due to ...
(Date:4/24/2014)... of prescription opioid overdose deaths was outlined yesterday in ... leaders of agencies in the U.S. Department of Health ... care providers to expand their use of medications to ... a number of misperceptions that have limited access to ... medications can be used in combination with behavior therapies ...
(Date:4/24/2014)... It is better to give than to receive ... a new study suggests. , The study found that 15- ... giving their money to family members, are less likely to ... taking risks or keeping the money for themselves. , The ... National Academy of Sciences . , The study focused on ...
Breaking Medicine News(10 mins):Health News:Take the bat, leave the candy 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Boring cells could hold the key to heart disease 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Study: Altruistic adolescents less likely to become depressed 2
... Physicians Service,Insurance Corporation (WPS) filed a lawsuit in Milwaukee ... WPS,s contractual,relationship with HealthEOS by MultiPlan, an independent primary ... terms of its contract with,WPS. This action was taken ... face with Aurora and HealthEOS to resolve these issues ...
... SeeMore,s Playhouse(TM) delivers fun,and educational Red Cross Fire ... The American Red Cross,and Safety4Kids(R), LLC have ... entertainment DVD entitled SeeMore,s Playhouse: Fire,Safety. Fire Safety ... expertise,will be incorporated into programming designed to teach ...
... Corps,Battleground Poll of likely voters in swing congressional ... final FY 2008 budget,deliberations, and released today, found ... with 57% of Democrats and 56% of,Republicans opposing ... also found 53% of Democrats and 49% of ...
... consumers , , TUESDAY, Jan. 15 (HealthDay News) -- Food ... animals are as safe to eat as foods from conventionally ... , The announcement seemingly lifts the last government barrier to ... cloned cattle, swine, goats and their offspring. , However, food ...
... Comprehensive Cancer Center at Georgetown University Medical Center have ... be the Achilles heel for breast tumors that are ... common type of breast cancer. , In the ... say the findings support testing an experimental class of ...
... Even those needing most urgent care are waiting more, study ... thing you want to hear in the emergency room when ... you have to wait before you can get treatment. , ... fact, new research found that waiting times in emergency rooms ...
Cached Medicine News:Health News:Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 2Health News:American Red Cross Partners With Safety4Kids(R) to Debut Children's Fire Safety DVD 2Health News:American Red Cross Partners With Safety4Kids(R) to Debut Children's Fire Safety DVD 3Health News:American Red Cross Partners With Safety4Kids(R) to Debut Children's Fire Safety DVD 4Health News:New Democracy Corps Battleground Poll of Swing Districts Finds Strong, Bi-Partisan Opposition to Cutting Medicare-Funded Nursing Home Care 2Health News:Foods From Cloned Animals Safe to Eat: FDA 2Health News:Foods From Cloned Animals Safe to Eat: FDA 3Health News:Foods From Cloned Animals Safe to Eat: FDA 4Health News:Findings point to molecular 'Achilles heel' for half of breast cancer tumors 2Health News:Findings point to molecular 'Achilles heel' for half of breast cancer tumors 3Health News:ER Wait Times Getting Longer 2Health News:ER Wait Times Getting Longer 3Health News:ER Wait Times Getting Longer 4
(Date:1/15/2014)... 15, 2014 Tegra Medical is very pleased to announce ... its new Chief Executive Officer.  Mark was promoted from his ... overseen the company,s four facilities in Massachusetts ... King joined Tegra Medical in 2012 with 20+ years of ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... PITTSBURGH , June 18 Mylan Inc. (Nasdaq: MYL ... approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated ... 20 mg, 40 mg and 80 mg, the generic version of Merck ... be distributed by Mylan Pharmaceuticals Inc. , ...
... InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b ... Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association ... at 2:45 pm EDT during the "Update on BARI ... , , ...
Cached Medicine Technology:Mylan Receives Approval for Generic Version of Zocor® Tablets 2InteKrin Therapeutics to Present Phase 2b Clinical Data for Edema at the 2010 American Diabetes Association Annual Meeting 2
... combining intra-operative ultrasound imaging ... Surgical Navigation Technologies has ... called SonoNav Intra-operative Imaging ... on the high quality, ...
... Ateles is a scaleable ... any volume of platelet plasma ... plasma or buffy coat must ... equipment and techniques. Starting volume ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The SB Charit is a prosthesis system consisting of two endplates made of high quality cobalt chromium alloy with an ultra high molecular weight polyethylene sliding core placed between them....
Medicine Products: